Events & Presentations

08/11/2024

Nykode Therapeutics VB10.NEO update – presentation

10/01/2024

42nd Annual J.P. Morgan Healthcare Conference, January 10, 2024 – presentation

14/12/2023

DNB Nordic Healthcare Conference, December 14, 2023 – presentation

17/11/2023

Jefferies Healthcare Conference, November 16, 2023 – presentation

27/09/2023

Nykode Therapeutics – Capital Markets Day in Oslo on September 27, 2023 – presentation

20/09/2023

Nykode Therapeutics – Capital Markets Day in New York on September 20, 2023 – presentation

11/09/2023

H.C. Wainwright 25th Annual Global Investment Conference, September 11, 2023 – presentation

07/06/2023

Jefferies Healthcare Conference, June 7, 2023 – presentation

07/06/2023

ABGSC Life Science Summit 30-31 May 2023 – presentation

19/04/2023

Nykode Therapeutics – Final Results from the Phase 2 VB-C-02 trial – presentation

18/04/2023

Nykode Therapeutics announces positive final results from its Phase 2 trial of VB10.16 in combination with PD-L1 inhibitor atezolizumab in advanced cervical cancer – presentation

09/01/2023

Nykode Therapeutics – Presentation at the 41st Annual J.P. Morgan Healthcare Conference

20/12/2022

Nykode Therapeutics – Clinical development plan for VB10.16 – presentation

24/11/2022

ABG oncology seminar, November 23, 2022 – presentation

07/11/2022

Credit Suisse 31st Annual Healthcare conference, 2022 – presentation

26/10/2022

Nykode Therapeutics Announces Presentation of Positive Immunogenicity Results from Phase 1/2a Study of VB10.NEO, an Individualized Therapeutic Cancer Vaccine, at the Neoantigen-Based Therapies Summit

27/09/2022

Initial Results from the Phase 1/2 Trial of the T Cell SARS-CoV-2 Vaccine Candidate VB10.2210 – presentation

13/09/2022

H.C. Wainwright 24th Annual Global Investment Conference, September 13, 2022 – presentation

08/06/2022

Jefferies Healthcare Conference, June 8-10, 2022 – presentation

12/05/2022

Capital Markets Day in Oslo on May 12, 2022 – presentation

09/05/2022

Nykode Therapeutics – Interim results from Phase 2 trial with VB10.16 in combination with atezolizumab in advanced cervical cancer – presentation

20/04/2022

Kempen Life Sciences Conference – April 20, 2021

01/04/2022

Nykode Therapeutics – full year 2021 financial results and corporate presentation

17/02/2022

SVB Leerink 2022 Global Healthcare Conference – February 18, 2022

19/01/2022

SEB Nordic Healthcare Seminar

05/01/2022

Company update on T cell focused COVID-19 vaccine candidate

23/11/2021

ABGSC Oncology Seminar

23/11/2021

Nykode Therapeutics company update

13/11/2019

VACCIBODY PRESENTATION, CAPITAL MARKETS DAY – OSLO, 12 NOVEMBER 2019

03/04/2019

COMPANY PRESENTATION – 13 FEBRUARY 2019

03/04/2019

LUNCH MEETING ARCTIC SECURITIES – 10 OCTOBER 2018

13/02/2019

COMPANY PRESENTATION – February 2019

Events & Presentations

Contact